Pharmacology
News
Another study ties statins to T2D: Should practice change?
“When using rosuvastatin over atorvastatin, we ... emphasize the importance of meticulous monitoring and appropriate lifestyle interventions to...
Conference Coverage
Antidepressants ‘don’t blunt’ semaglutide and weight loss
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
Conference Coverage
Endoscopic remission doubled with risankizumab vs. ustekinumab in Crohn’s disease
AT UEG WEEK 2023
COPENHAGEN –
Latest News
Taking a new obesity drug and birth control pills? Be careful
“It [the warning] was in the product insert, but clinically speaking, I don’t know if it was at the top of providers’ minds when they were...
Latest News
FDA approves bimekizumab for moderate to severe plaque psoriasis in adults
With this approval, bimekizumab becomes the only interleukin (IL)-17A and IL-17F inhibitor approved for the treatment of these patients.
Latest News
Once-weekly topical therapy shows promise for moderate to severe acne
In vitro studies have found that components of S. lacustris, a freshwater sponge, have effects that include antimicrobial activity...
Latest News
FDA approves nivolumab for resected stage IIB/C melanoma
Approval was based on findings from a phase 3 trial, which randomly assigned 790 patients to receive nivolumab or placebo by intravenous infusion...
News
Approximately 20% of U.S. adults are diagnosed with arthritis
New data show disproportionate arthritis prevalence among women, veterans, non-Hispanic White individuals, and those aged 45 years and older.
News
Abatacept, certolizumab: Best biologics in early RA
The study was the first head-to-head comparison of multiple biologics plus methotrexate vs. active conventional DMARDs plus steroid bridging for...
News
Narcolepsy med shows early promise for adult ADHD
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor that shares some of the properties of current ADHD medications.